Literature DB >> 2571072

Binding of vinblastine to stabilized microtubules.

W D Singer1, M A Jordan, L Wilson, R H Himes.   

Abstract

Addition of 2-200 microM vinblastine to microtubules at steady state in vitro causes the microtubules to depolymerize, with the formation of protofilament spirals and other aggregated forms of microtubule protein. The presence of such spirals and protein aggregates, which are difficult to separate from microtubules, has complicated attempts to measure the binding of vinblastine to microtubules. We have found that stabilizing bovine brain microtubules in vitro with dimethyl sulfoxide, taxol, or a combination of dimethyl sulfoxide and taxol prevents or greatly retards the formation of protofilamentous spirals, thus permitting us to measure the binding of vinblastine to intact microtubules. Reciprocal plots of binding data indicate the presence of 1.4-1.7 vinblastine binding sites/mol of tubulin in the microtubule, with a Ka of approximately 3-4 x 10(3) M-1. The Ka value obtained is within 1 order of magnitude of the apparent intrinsic binding constant for the binding of vinblastine to tubulin dimers. The results support the idea that depolymerization of microtubules by intermediate and high concentrations of vinblastine occurs by stoichiometric binding of vinblastine to tubulin along the microtubule surface.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571072

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules.

Authors:  Manu Lopus; Emin Oroudjev; Leslie Wilson; Sharon Wilhelm; Wayne Widdison; Ravi Chari; Mary Ann Jordan
Journal:  Mol Cancer Ther       Date:  2010-10       Impact factor: 6.261

2.  Different effects of vinblastine on the polymerization of isotypically purified tubulins from bovine brain.

Authors:  Israr A Khan; Richard F Ludueña
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

3.  Tau isoform-specific stabilization of intermediate states during microtubule assembly and disassembly.

Authors:  Rebecca L Best; Nichole E LaPointe; Jiahao Liang; Kevin Ruan; Madeleine F Shade; Leslie Wilson; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

Review 4.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

5.  Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.

Authors:  M A Jordan; R J Toso; D Thrower; L Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

6.  Synthesis of 5,7-disubstituted-4-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amines as microtubule inhibitors.

Authors:  Aleem Gangjee; Sonali Kurup; Charles D Smith
Journal:  Bioorg Med Chem       Date:  2013-01-03       Impact factor: 3.641

7.  Vinblastine suppresses dynamics of individual microtubules in living interphase cells.

Authors:  R Dhamodharan; M A Jordan; D Thrower; L Wilson; P Wadsworth
Journal:  Mol Biol Cell       Date:  1995-09       Impact factor: 4.138

8.  Antiproliferative Activity of Crocin Involves Targeting of Microtubules in Breast Cancer Cells.

Authors:  Rupali R Hire; Shalini Srivastava; Melissa B Davis; Ananda Kumar Konreddy; Dulal Panda
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 9.  NMR Meets Tau: Insights into Its Function and Pathology.

Authors:  Guy Lippens; Isabelle Landrieu; Caroline Smet; Isabelle Huvent; Neha S Gandhi; Benoît Gigant; Clément Despres; Haoling Qi; Juan Lopez
Journal:  Biomolecules       Date:  2016-06-07

10.  Mitotic slippage and the subsequent cell fates after inhibition of Aurora B during tubulin-binding agent-induced mitotic arrest.

Authors:  Yasuo Tsuda; Makoto Iimori; Yuichiro Nakashima; Ryota Nakanishi; Koji Ando; Kippei Ohgaki; Hiroyuki Kitao; Hiroshi Saeki; Eiji Oki; Yoshihiko Maehara
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.